Study Stopped
Study was discontinued due to a lack of feasibility.
Behavioral Nudge in Colorectal Cancer Screening
Role of Behavioral Nudge as a Tool to Increase CRC Screening at an Urban Center Outpatient Clinic
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The purpose of this study is to evaluate if a behavioral nudge principle known as social norm driver can be implemented to improve fecal immunochemical test (FIT) completion rates for patients' age 45-75 years old due for colorectal cancer screening at Bellevue Hospital Medicine Ambulatory Care Clinic. The study's endpoints include FIT screening completion rate and timeliness. Secondary analysis will look at demographic information such as age group, gender, prior screening, number of prior visits at the clinic.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started May 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 22, 2025
CompletedFirst Posted
Study publicly available on registry
January 28, 2025
CompletedStudy Start
First participant enrolled
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
ExpectedFebruary 25, 2026
February 1, 2026
1.1 years
January 22, 2025
February 23, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Time until the fecal immunochemical test (FIT) is returned to the clinic for processing
Study participants will be tracked for completion of their FIT screening test up until 3 months after the initial stool study was given.
Month 3
Percentage of participants who completed the FIT screening test
Study participants will be tracked for completion of their FIT screening test up until 3 months after the initial stool study was given.
Month 3
Study Arms (3)
Time Period 1
NO INTERVENTIONA FIT test is ordered by the provider and a patient care assistant (PCA) gives patient a FIT kit, which includes a specimen cup and instructions on how to use it, at the end of the visit prior to their departure.
Time Period 2
EXPERIMENTALA new information pamphlet is given to participants alongside the FIT kit at the end of the visit. The pamphlet contains an easy-to-read description of FIT screening adapted from the NYC department of health C5 Colorectal cancer (CRC) screening coalition pamphlet and lead-time CRC screening messaging tool, instructions on how to complete the test and the importance of FIT screening.
Time Period 3
EXPERIMENTALA new information pamphlet is given to participants along the FIT kit similar to "Time period 2", but includes a social norm driver in the pamphlet that displays the sub-par screening rate of our clinic compared to a collective New York State screening rate and a national screening rate goal set by the Centers for Disease Control and Prevention (CDC).
Interventions
The information pamphlet is given to participants at the end of the visit. The pamphlet contains an easy-to-read description of FIT screening adapted from the NYC department of health C5 Colorectal cancer (CRC) screening coalition pamphlet and lead-time CRC screening messaging tool, instructions on how to complete the test and the importance of FIT screening. The information pamphlet will also contain a social norm driver that displays the sub-par screening rate the clinic compared to a collective New York State screening rate and a national screening rate goal set by the CDC.
The information pamphlet is given to participants at the end of the visit. The pamphlet contains an easy-to-read description of FIT screening adapted from the NYC department of health C5 CRC screening coalition pamphlet and lead-time CRC screening messaging tool, instructions on how to complete the test and the importance of FIT screening.
Eligibility Criteria
You may qualify if:
- Patient at Bellevue Ambulatory Care Medicine Clinic between 1/1/2024 and 7/1/2024
- Age 45-75 years old
- Patient at Bellevue Ambulatory Care Resident Clinic
- Age 45-75 years old
- Has not had a FIT test within the past year
- Can read either English or Spanish
- Is able and willing to provide consent
- Patient at Bellevue Ambulatory Care Resident Clinic
- Age 45-75 years old
- Has not had a FIT test completed within the past year
- Can read either English or Spanish
- Is able and willing to provide consent
You may not qualify if:
- Patient at a clinic that is not Bellevue Ambulatory Care Resident Clinic
- Age outside of 45-75 years old
- Patient at a clinic that is not Bellevue Ambulatory Care Resident Clinic
- Age outside of 45-75 years old
- Has had a FIT test completed within the past year
- Cannot read either English or Spanish
- Patient at a clinic that is not Bellevue Ambulatory Care Resident Clinic
- Age outside of 45-75 years old
- Has had a FIT test completed within the past year
- Cannot read either English or Spanish
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
NYU Langone Health
New York, New York, 10016, United States
Study Officials
- STUDY DIRECTOR
Aasma Shaukat, MD
NYU Langone Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 22, 2025
First Posted
January 28, 2025
Study Start
May 1, 2025
Primary Completion
June 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
February 25, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
Individual Participant Data will not be available to other researchers. Access to this aggregated study database will be limited to HIPAA certified investigators who have been IRB-approved for participation in this study.